Liposomes coloaded with iopamidol/lipiodol as a res-targeted contrast agent for computed tomography imaging

Soonjae Kweon, Ho Joon Lee, Woo Jin Hyung, Jinsuk Suh, Joon Seok Lim, Soo Jeong Lim

Research output: Contribution to journalArticle

36 Citations (Scopus)

Abstract

Purpose: The need for computed tomography (CT) of reticuloendothelial system (RES)-rich organs such as the liver is increasing, particularly in patients with suspected hepatic metastasis. CT images of the liver have been improved by encapsulating currently used, water-soluble iodine contrast agent in liposomes. The present study was performed to investigate a possibility to overcome the limitations of entrapped iodine in liposomes by preparing liposomes co-loaded with iopamidol, a water-soluble iodinated compound, and lipiodol, an iodized oil. Methods: Iopamidol and lipiodol were simultaneously loaded in liposomes by modified reverse-phase evaporation method. The entrapped iodine concentration, mean particle size and polydispersity index of resulting liposomes were evaluated. Following intravenous injection of these liposomes into rats, CT scanning was performed. Results: Simultaneous loading of iopamidol and lipiodol into liposomes resulted in entrapped iodine concentrations as high as 49.2 iodine mg/ml. The mean particle size was 280 nm, and the mean polydispersity index was 0.230. CT scanning with these iopamidol/lipiodol (I/L) liposomes into rats resulted in more pronounced and more persistent increases in RES-rich organs, liver and spleen, compared with free liposomes or liposomes loaded with iopamidol alone. Conclusions: These findings indicate that I/L liposomes have the potential to allow thorough CT examination of RES-rich organs.

Original languageEnglish
Pages (from-to)1408-1415
Number of pages8
JournalPharmaceutical Research
Volume27
Issue number7
DOIs
Publication statusPublished - 2010 Jul 1

Fingerprint

Iopamidol
Ethiodized Oil
Liposomes
Contrast Media
Tomography
Imaging techniques
Iodine
Mononuclear Phagocyte System
Liver
Polydispersity
Particle Size
Rats
Particle size
Scanning
Water
Intravenous Injections
Evaporation

All Science Journal Classification (ASJC) codes

  • Biotechnology
  • Molecular Medicine
  • Pharmacology
  • Pharmaceutical Science
  • Organic Chemistry
  • Pharmacology (medical)

Cite this

Kweon, Soonjae ; Lee, Ho Joon ; Hyung, Woo Jin ; Suh, Jinsuk ; Lim, Joon Seok ; Lim, Soo Jeong. / Liposomes coloaded with iopamidol/lipiodol as a res-targeted contrast agent for computed tomography imaging. In: Pharmaceutical Research. 2010 ; Vol. 27, No. 7. pp. 1408-1415.
@article{e5f7cece26aa491a9ec4274b9e849d2d,
title = "Liposomes coloaded with iopamidol/lipiodol as a res-targeted contrast agent for computed tomography imaging",
abstract = "Purpose: The need for computed tomography (CT) of reticuloendothelial system (RES)-rich organs such as the liver is increasing, particularly in patients with suspected hepatic metastasis. CT images of the liver have been improved by encapsulating currently used, water-soluble iodine contrast agent in liposomes. The present study was performed to investigate a possibility to overcome the limitations of entrapped iodine in liposomes by preparing liposomes co-loaded with iopamidol, a water-soluble iodinated compound, and lipiodol, an iodized oil. Methods: Iopamidol and lipiodol were simultaneously loaded in liposomes by modified reverse-phase evaporation method. The entrapped iodine concentration, mean particle size and polydispersity index of resulting liposomes were evaluated. Following intravenous injection of these liposomes into rats, CT scanning was performed. Results: Simultaneous loading of iopamidol and lipiodol into liposomes resulted in entrapped iodine concentrations as high as 49.2 iodine mg/ml. The mean particle size was 280 nm, and the mean polydispersity index was 0.230. CT scanning with these iopamidol/lipiodol (I/L) liposomes into rats resulted in more pronounced and more persistent increases in RES-rich organs, liver and spleen, compared with free liposomes or liposomes loaded with iopamidol alone. Conclusions: These findings indicate that I/L liposomes have the potential to allow thorough CT examination of RES-rich organs.",
author = "Soonjae Kweon and Lee, {Ho Joon} and Hyung, {Woo Jin} and Jinsuk Suh and Lim, {Joon Seok} and Lim, {Soo Jeong}",
year = "2010",
month = "7",
day = "1",
doi = "10.1007/s11095-010-0135-5",
language = "English",
volume = "27",
pages = "1408--1415",
journal = "Pharmaceutical Research",
issn = "0724-8741",
publisher = "Springer New York",
number = "7",

}

Liposomes coloaded with iopamidol/lipiodol as a res-targeted contrast agent for computed tomography imaging. / Kweon, Soonjae; Lee, Ho Joon; Hyung, Woo Jin; Suh, Jinsuk; Lim, Joon Seok; Lim, Soo Jeong.

In: Pharmaceutical Research, Vol. 27, No. 7, 01.07.2010, p. 1408-1415.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Liposomes coloaded with iopamidol/lipiodol as a res-targeted contrast agent for computed tomography imaging

AU - Kweon, Soonjae

AU - Lee, Ho Joon

AU - Hyung, Woo Jin

AU - Suh, Jinsuk

AU - Lim, Joon Seok

AU - Lim, Soo Jeong

PY - 2010/7/1

Y1 - 2010/7/1

N2 - Purpose: The need for computed tomography (CT) of reticuloendothelial system (RES)-rich organs such as the liver is increasing, particularly in patients with suspected hepatic metastasis. CT images of the liver have been improved by encapsulating currently used, water-soluble iodine contrast agent in liposomes. The present study was performed to investigate a possibility to overcome the limitations of entrapped iodine in liposomes by preparing liposomes co-loaded with iopamidol, a water-soluble iodinated compound, and lipiodol, an iodized oil. Methods: Iopamidol and lipiodol were simultaneously loaded in liposomes by modified reverse-phase evaporation method. The entrapped iodine concentration, mean particle size and polydispersity index of resulting liposomes were evaluated. Following intravenous injection of these liposomes into rats, CT scanning was performed. Results: Simultaneous loading of iopamidol and lipiodol into liposomes resulted in entrapped iodine concentrations as high as 49.2 iodine mg/ml. The mean particle size was 280 nm, and the mean polydispersity index was 0.230. CT scanning with these iopamidol/lipiodol (I/L) liposomes into rats resulted in more pronounced and more persistent increases in RES-rich organs, liver and spleen, compared with free liposomes or liposomes loaded with iopamidol alone. Conclusions: These findings indicate that I/L liposomes have the potential to allow thorough CT examination of RES-rich organs.

AB - Purpose: The need for computed tomography (CT) of reticuloendothelial system (RES)-rich organs such as the liver is increasing, particularly in patients with suspected hepatic metastasis. CT images of the liver have been improved by encapsulating currently used, water-soluble iodine contrast agent in liposomes. The present study was performed to investigate a possibility to overcome the limitations of entrapped iodine in liposomes by preparing liposomes co-loaded with iopamidol, a water-soluble iodinated compound, and lipiodol, an iodized oil. Methods: Iopamidol and lipiodol were simultaneously loaded in liposomes by modified reverse-phase evaporation method. The entrapped iodine concentration, mean particle size and polydispersity index of resulting liposomes were evaluated. Following intravenous injection of these liposomes into rats, CT scanning was performed. Results: Simultaneous loading of iopamidol and lipiodol into liposomes resulted in entrapped iodine concentrations as high as 49.2 iodine mg/ml. The mean particle size was 280 nm, and the mean polydispersity index was 0.230. CT scanning with these iopamidol/lipiodol (I/L) liposomes into rats resulted in more pronounced and more persistent increases in RES-rich organs, liver and spleen, compared with free liposomes or liposomes loaded with iopamidol alone. Conclusions: These findings indicate that I/L liposomes have the potential to allow thorough CT examination of RES-rich organs.

UR - http://www.scopus.com/inward/record.url?scp=77953615786&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77953615786&partnerID=8YFLogxK

U2 - 10.1007/s11095-010-0135-5

DO - 10.1007/s11095-010-0135-5

M3 - Article

C2 - 20424895

AN - SCOPUS:77953615786

VL - 27

SP - 1408

EP - 1415

JO - Pharmaceutical Research

JF - Pharmaceutical Research

SN - 0724-8741

IS - 7

ER -